Basic Information
Basic information for SOX2-OT-260-17aa
Peptide Name SOX2-OT-260-17aa
Genome Position chr3:181740384-181740434[+]
Species Human
Peptide Sequence MVEEVLPRLLGPGSCKQ
Peptide Length 17
Unique No (SOX2-OT-203-17aa,SOX2-OT-207-17aa,SOX2-OT-213-17aa,SOX2-OT-218-17aa,SOX2-OT-225-17aa,SOX2-OT-234-17aa,SOX2-OT-249-17aa,SOX2-OT-261-17aa,SOX2-OT-262-17aa,SOX2-OT-263-17aa,SOX2-OT-265-17aa,SOX2-OT-268-17aa,SOX2-OT-272-17aa,SOX2-OT-275-17aa,SOX2-OT-276-17aa,SOX2-OT-280-17aa,SOX2-OT-282-17aa,SOX2-OT-283-17aa,SOX2-OT-285-17aa,SOX2-OT-286-17aa,SOX2-OT-287-17aa,SOX2-OT-291-17aa,SOX2-OT-292-17aa-2,SOX2-OT-293-17aa-1,SOX2-OT-294-17aa,SOX2-OT-295-17aa,SOX2-OT-296-17aa,SOX2-OT-297-17aa,SOX2-OT-298-17aa,SOX2-OT-299-17aa,SOX2-OT-300-17aa,SOX2-OT-301-17aa,SOX2-OT-303-17aa,SOX2-OT-304-17aa)
Grand Average of Hydropathicity 0.0294
Relative Molecular Mass 2144.47
Experimental Evidences 2:lncORF,ribo
lncRNA ID/Name ENSG00000242808;SOX2-OT
Transcript ID/Name ENST00000642218;SOX2-OT-260
Transcript Length 1500
Coding Ability 0.306
DNA Sequence Corresponding to Peptide ATGGTAGAGGAGGTCCTTCCAAGACTTCTAGGACCTGGATCATGTAAGCAG
Experimental Evidences
   lncORF
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :